Basel Medical Group Ltd Ordinary Shares (BMGL) — Net Asset Quality Index
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Net Asset Quality Index of 28.9% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $16.85 Million minus total liabilities of $11.99 Million yields net assets of $4.86 Million. A higher index indicates a stronger, lower-leverage balance sheet. See operational self-sufficiency of Basel Medical Group Ltd Ordinary Shares to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Basel Medical Group Ltd Ordinary Shares Net Asset Quality Index Over Time (2022–2025)
This chart shows how Basel Medical Group Ltd Ordinary Shares's Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of September 2025, the index stands at 28.9%, representing net assets of $4.86 Million against total assets of $16.85 Million USD. Explore Basel Medical Group Ltd Ordinary Shares (BMGL) cash conversion ratio to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Basel Medical Group Ltd Ordinary Shares (2022–2025)
The table below presents the year-by-year Net Asset Quality Index for Basel Medical Group Ltd Ordinary Shares from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see BMGL market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 28.9% | $4.86 Million | $16.85 Million | $11.99 Million | ▼ -17.5 pp |
| 2024 | 46.4% | $7.56 Million | $16.31 Million | $8.75 Million | ▲ +10.7 pp |
| 2023 | 35.7% | $5.49 Million | $15.38 Million | $9.89 Million | ▲ +13.7 pp |
| 2022 | 22.0% | $3.71 Million | $16.85 Million | $13.14 Million | — |